AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹65 Cr | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹9.72 Cr |
| Mar2023 | ₹-163 Cr |
| Mar2022 | ₹260 Cr |
| Mar2021 | - |
How is Cash Flow from Financing Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 572.92 | |
| Mar2024 | ₹9.72 Cr | Positive | |
| Mar2023 | ₹-163 Cr | Negative | |
| Mar2022 | ₹260 Cr | 0 | |
| Mar2021 | - | - | |
Compare Cash Flow from Financing Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,337.7 Cr | 1.1% | 9.9% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 1.1% |
9.9% |
-18.9% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses